Eplontersen User Reviews & Ratings
Brand names: Wainua
Eplontersen has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Transthyretin-Related Amyloidosis | 1 reviews for Transthyretin-Related Amyloidosis | 6 medications |
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about eplontersen
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
For Transthyretin-Related Amyloidosis "I was initially diagnosed with advanced stage HATTR and peripheral neuropathy. I have been taking Wainua for 1 1/2 years. During this time, I have not experienced any side effects. Wainua has substantially reduced my incidents of feet and all-over joint pain. Also, my trigger finger locking is rare, and my finger no longer looks like a raised inverted V. It’s very significantly flattened. I can walk 2 miles and do not need assistive devices for mobility. It helps me to be independent in ADL. I’m on 45 mg subcutaneous, auto self-injector needle, every 30 days. Administration is extremely easy. Training is provided. I’m quite satisfied with the relief Wainua is providing."